Literature DB >> 17126392

Transrectal ultrasonography and plasma progestin profiles identifies feto-placental compromise in mares with experimentally induced placentitis.

Steffani Morris1, Audrey A Kelleman, Robert J Stawicki, Peter J Hansen, Peter C Sheerin, Barbara R Sheerin, Dale L Paccamonti, Michelle M LeBlanc.   

Abstract

Transrectal ultrasonography of the caudal uterus and a progestin profile were evaluated for accuracy in identifying mares with feto-placental compromise in a model of placentitis. Twenty-two pregnant ponies were divided into four groups: (1) control mares (n=5); (2) instrumented controls (n=2); (3) instrumented inoculated mares (n=11); (4) inoculated mares (n=4). Mares in Groups 3 and 4 were inoculated with Streptococcus equi subsp. zooepidemicus. Maternal plasma progestins, vulvar discharge, mammary gland development, combined thickness of the uterus and placenta (CTUP) and placental separation were evaluated weekly before instrumentation, inoculation or Day 320 (Groups 1 and 2) and, thereafter, either daily (first three measurements) or several times weekly (last two measurements). Plasma progestin profiles were plotted to identify pattern characteristics. An abbreviated profile was created, consisting of four progestin samples collected at 48-h intervals, with Sample 1 collected the day before inoculation or on Day 285 in controls. Profiles were considered abnormal if Samples 2, 3, or 4 increased or decreased by more than 50% of Sample 1. A CTUP>1.0 cm or placental separation were considered abnormal. Placentitis was confirmed by histology of fetal membranes. Control mares had normal progestin profiles, transrectal ultrasonographic and clinical examinations. Control foals were born after Day 329; six were viable and one died after dystocia. All inoculated mares developed placentitis and foaled before Day 314. Thirteen of 15 foals were not viable. All inoculated mares had abnormal progestin profiles and 13 of the 15 were identified by the abbreviated progestin profile. Transrectal CTUP was affected by gestational age and increased after inoculation (P<0.05). Nine of 15 inoculated mares had a CTUP>1.0 cm by 5-day post-inoculation. By performing both tests, 20 of 22 mares were correctly identified with respect to pregnancy outcome. However, three inoculated mares exhibited minimal clinical signs and likely would not be examined in a clinical setting. These tests were diagnostic for identifying feto-placental compromise in the mare.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126392     DOI: 10.1016/j.theriogenology.2006.05.021

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  5 in total

1.  Ascending placentitis in the mare: A review.

Authors:  C Cummins; S Carrington; E Fitzpatrick; V Duggan
Journal:  Ir Vet J       Date:  2008-05-01       Impact factor: 2.146

2.  A clinical case of equine fungal placentitis with reference to hormone profiles and ultrasonography.

Authors:  Harutaka Murase; Hidekazu Niwa; Yoshinari Katayama; Fumio Sato; Tetsuro Hada; Yasuo Nambo
Journal:  J Equine Sci       Date:  2016-02-03

3.  Combined thickness of the uterus and placenta and ultrasonographic examinations of uteroplacental tissues in normal pregnancy, placentitis, and abnormal parturitions in heavy draft horses.

Authors:  Yuki Kimura; Shingo Haneda; Takahiro Aoki; Hidefumi Furuoka; Wataru Miki; Natsuko Fukumoto; Motozumi Matsui; Yasuo Nambo
Journal:  J Equine Sci       Date:  2018-03-23

4.  Ultrasonographic evaluation of equine fetal growth throughout gestation in normal mares using a convex transducer.

Authors:  Harutaka Murase; Yoshiro Endo; Takeru Tsuchiya; Yasumitsu Kotoyori; Mitsumori Shikichi; Katsumi Ito; Fumio Sato; Yasuo Nambo
Journal:  J Vet Med Sci       Date:  2014-03-24       Impact factor: 1.267

5.  Aborted fetal sizes of Thoroughbred horses in Hidaka, Japan, between 2005 and 2015.

Authors:  Harutaka Murase; Masaki Miyazawa; Takehiro Harada; Midori Ozawa; Fumio Sato; Tetsuro Hada
Journal:  J Equine Sci       Date:  2017-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.